MoonLake Immunotherapeutics (MLTX) Prepaid Assets (2020 - 2026)
MoonLake Immunotherapeutics (MLTX) recorded quarterly Prepaid Assets of $33.0 million in Q1 2026, up 44.19% quarter-over-quarter from $22.9 million in Q4 2025, and up 42.39% on a YoY basis from $23.1 million in Q1 2025.
MoonLake Immunotherapeutics (MLTX) Prepaid Assets (2020 - 2026) Analysis & Trends
MoonLake Immunotherapeutics' Prepaid Assets history runs 7 years deep, the most recent figure standing at $33.0 million for Q1 2026.
- In Q1 2026, Prepaid Assets rose 42.39% year-over-year to $33.0 million; the TTM figure through Mar 2026 stood at $33.0 million (up 42.39% YoY), while the FY2025 annual figure was $22.9 million, down 2.4% from the prior year.
- Prepaid Assets was $33.0 million for Q1 2026 at MoonLake Immunotherapeutics, up from $22.9 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $33.0 million in Q1 2026 to a low of $135916.0 in Q1 2022.
- Historically, Prepaid Assets has averaged $12.9 million across 5 years, with a median of $5.1 million in 2022.
- Biggest YoY gain for Prepaid Assets was 2415.82% in 2022; the steepest drop was 53.07% in 2022.
- A 5-year view of Prepaid Assets shows it stood at $4.2 million in 2022, then tumbled by 49.7% to $2.1 million in 2023, then soared by 1013.97% to $23.4 million in 2024, then retreated by 2.4% to $22.9 million in 2025, then soared by 44.19% to $33.0 million in 2026.
- The last three Prepaid Assets figures came in at $33.0 million (Q1 2026), $22.9 million (Q4 2025), and $26.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - |
| 10 | MoonLake Immunotherapeutics | 1.25 Bn | 888.66 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 32.96 Mn |
| Dec 31, 2025 | 22.86 Mn |
| Sep 30, 2025 | 26.71 Mn |
| Jun 30, 2025 | 26.99 Mn |
| Mar 31, 2025 | 23.15 Mn |
| Dec 31, 2024 | 23.42 Mn |
| Sep 30, 2024 | 15.98 Mn |
| Jun 30, 2024 | 15.41 Mn |
| Mar 31, 2024 | 5.04 Mn |
| Dec 31, 2023 | 2.10 Mn |
| Sep 30, 2023 | 3.31 Mn |
| Jun 30, 2023 | 3.96 Mn |
| Mar 31, 2023 | 3.08 Mn |
| Dec 31, 2022 | 4.18 Mn |
| Sep 30, 2022 | 4.48 Mn |
| Jun 30, 2022 | 5.11 Mn |
| Mar 31, 2022 | 135,916.00 |
| Dec 31, 2021 | 1.45 Mn |
| Sep 30, 2021 | 178,041.00 |
| Jun 30, 2021 | 233,523.00 |